At Diagnostic Imaging, we pride ourselves on staying ahead of the clinical curve. We believe that keeping you informed about the clinical aspects of new technology helps you in your practice and in making purchasing decisions.
At Diagnostic Imaging, we pride ourselves on staying ahead of the clinical curve. We believe that keeping you informed about the clinical aspects of new technology helps you in your practice and in making purchasing decisions.
It's in that spirit that we present this month's cover story on a site's initial experiences with a 64-slice CT scanner. Written by CT luminary and Diagnostic Imaging editorial advisor Dr. Elliot Fishman and his colleagues at Johns Hopkins Hospital, the article offers a glimpse of what you can expect as the new multislice scanners enter the mainstream. As you might expect, cardiovascular imaging tops the list, thanks to the ability to visualize the coronary arteries without motion artifact and to conduct carotid and peripheral studies without venous contamination.
The article also predicts that the 64-slice scanners will move CT to a stage where it can perform functional imaging outside the brain, perhaps by charting vascular changes that could presage future metastatic disease.
Leading up to and during the RSNA meeting, a lot of buzz surrounded the new generation of multislice scanners. We've devoted considerable attention to them: in the Tech Watch section of this issue, in the Technology Advisor supplement in November, and in this month's cover story.
Although few of the new multislice scanners exist in the field at this point, most radiologists in practice today will eventually interpret the images they generate, and we believe they are interested in knowing what's headed their way. Presenting that information is part of our mission.
John C. Hayes is editor of Diagnostic Imaging
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).